High-Yield Oncology Safety and Emergency Tables
Key Takeaways
- Oncologic emergencies (16% of the blueprint) test rapid recognition, first nursing actions, escalation, and patient education.
- The safest OCN answer usually protects airway, circulation, neurologic function, vascular access integrity, or infection control before lower-urgency teaching.
- High-yield emergencies include febrile neutropenia (ANC under 500, or under 1,000 and falling), tumor lysis syndrome, hypercalcemia, spinal cord compression, superior vena cava syndrome, and cardiac tamponade.
- Modern OCN review must include immune-related adverse events and immune effector cell toxicities such as cytokine release syndrome (CRS) and ICANS.
- Tables should be drilled as trigger-to-action prompts, not read passively.
High-Yield Oncology Safety and Emergency Tables
Use red flags, not memorized paragraphs
Final review for oncology safety should feel like triage practice. The OCN exam asks what the nurse should do first, which finding is most concerning, what teaching needs follow-up, or which patient needs immediate evaluation. The best answer usually protects airway, breathing, circulation, neurologic function, infection control, or tissue integrity.
Stay inside RN scope: assess, stop unsafe administration, maintain access, initiate ordered emergency protocols, notify the provider, activate rapid response, educate, and document. Answers that have the RN independently prescribe, or that delay care to "reassure" the patient, are usually distractors.
Emergency trigger table
| Emergency | Classic clues (with thresholds) | Priority nursing response |
|---|---|---|
| Febrile neutropenia / sepsis | Temp 38.3C once or 38.0C for 1 hour with ANC under 500 (or under 1,000 and falling); chills, hypotension, tachycardia | Cultures then antibiotics within ~1 hour; rapid assessment; escalate |
| Tumor lysis syndrome (TLS) | High K+, high phosphate, LOW calcium, high uric acid, rising creatinine after cytotoxic therapy | Continuous telemetry, hydration, monitor labs, urgent provider notice |
| Hypercalcemia | Corrected calcium above ~10.5 mg/dL; weakness, constipation, polyuria, confusion, short QT | Assess hydration and mentation, fall precautions, isotonic fluids per orders |
| Spinal cord compression | New or worsening back pain, leg weakness, sensory level, bowel/bladder change | Neuro assessment, urgent escalation, dexamethasone/MRI per orders, limit mobility |
| Superior vena cava syndrome (SVCS) | Face/neck/arm swelling, dyspnea, distended chest veins, headache | Elevate head of bed, assess airway/breathing, urgent provider notice |
| Cardiac tamponade | Dyspnea, hypotension, muffled heart sounds, jugular venous distention (Beck triad) | Emergency assessment, oxygen/support, immediate escalation |
| Increased intracranial pressure | Headache, vomiting, vision change, altered mentation, seizures | Neuro assessment, protect airway, urgent escalation |
Note the trap: in TLS calcium is low (it binds excess phosphate), even though hypercalcemia is itself a separate emergency.
Infusion and hazardous drug safety
| Situation | First move | Avoid |
|---|---|---|
| Suspected anaphylaxis (wheeze, hypotension, tongue swelling) | Stop infusion, keep IV access, assess ABCs, call for help, epinephrine per protocol | Reassuring the patient without assessing |
| Mild infusion reaction | Follow protocol, assess vitals/symptoms, notify as indicated | Restarting without orders |
| Vesicant extravasation | Stop infusion, leave catheter if policy requires, aspirate/antidote if directed, notify | Flushing the line or pulling access before policy steps |
| Hazardous spill | Use the spill kit and PPE per policy | Cleaning with bare hands |
| Oral hazardous drug at home | Teach safe storage, glove handling, separate disposal, missed-dose rule | Crushing or splitting unless specifically instructed |
Infusion items separate candidates who know a concept from those who choose the safe first action. Wheezing, hypotension, tongue swelling, chest tightness, or respiratory distress means stop the infusion and assess. Possible extravasation means do not flush. Hazardous exposure means protect staff, caregivers, and the environment first.
Immune-related emergencies
Checkpoint inhibitors (the -mab agents like pembrolizumab, nivolumab, ipilimumab) cause immune-related adverse events (irAEs): pneumonitis, colitis, hepatitis, endocrinopathies, nephritis, myocarditis, and severe skin reactions. CAR T-cell and bispecific antibody therapies cause cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Fever after immune effector therapy is never "routine" until assessed.
| Toxicity | Red flags | OCN action logic |
|---|---|---|
| Pneumonitis | New cough, dyspnea, hypoxia | Escalate promptly; never label it expected fatigue |
| Colitis | Persistent or bloody diarrhea, cramping, dehydration | Notify the team; avoid casual antidiarrheal self-care advice |
| Endocrinopathy | Profound fatigue, headache, hypotension, glucose/thyroid shift | Assess and escalate; presentation can be subtle |
| Myocarditis | Chest pain, dyspnea, arrhythmia, troponin rise | Treat as life-threatening; urgent escalation |
| CRS | Fever, hypotension, hypoxia after immune therapy | Urgent assessment, protocol-based response (often tocilizumab) |
| ICANS | Confusion, aphasia, tremor, deteriorating handwriting, seizure | Neurologic emergency; escalate immediately |
Practice method
Cover the action column and recite the first response; then cover the clue column and name the triggering symptoms. This active drill is faster than rereading and mirrors timed exam performance. Quick recall prompts: fever plus possible neutropenia is urgent; new back pain with weakness is cord compression until proven otherwise; new dyspnea during infusion is stop-and-assess; new confusion after immune effector therapy is ICANS until ruled out; abnormal labs matter most when paired with symptoms, a worsening trend, or high-risk therapy.
Why "first action" beats "correct diagnosis" on the OCN
Many candidates lose emergency items not because they cannot name the syndrome but because they pick a real, helpful action that is not the first one. The exam writes options where two or three choices are all reasonable later steps. The discipline is to ask: of these, which protects life or limb soonest and stays within RN scope?
Work a representative scenario. A patient three days after induction chemotherapy for acute leukemia spikes a temperature of 38.5C; the morning ANC was 300. Options might include: notify the provider, draw blood cultures, administer scheduled antiemetics, and document the temperature. The keyed first action is to recognize febrile neutropenia and move quickly toward cultures and the sepsis bundle — the standard is broad-spectrum antibiotics within roughly one hour of recognized neutropenic fever. Documentation and antiemetics are real tasks, but they do not address the time-critical infection risk.
A second pattern: a patient with lung cancer reports facial swelling and morning headache that worsens when bending forward, with distended neck veins. That is superior vena cava syndrome; elevating the head of the bed and assessing the airway come before reassurance or routine teaching. Train your eye to separate the safe-now action from the merely-appropriate one, and the emergency domain becomes one of the most predictable on the test.
A patient receiving an IV anticancer agent reports burning at the peripheral IV site and swelling is now visible. What is the best first nursing action?
Which symptom cluster is most concerning for spinal cord compression in a patient with metastatic cancer?
A patient develops fever, hypotension, and hypoxia shortly after bispecific antibody treatment. Which toxicity should the nurse suspect first?